Our website will soon be relaunched with a fresh look and improved user experience. Take a look by visiting our test site.
Call us 24/7 at (888) 552-6760
Cancer Treatment Centers of America

CTCA Lung Cancer Center in Tulsa

"Our collaborative, multidisciplinary approach, combined with our access to state-of-the-art equipment and research trials, gives us the opportunity to present patients with as many options as possible for their care."

Your treatment options

Because lung cancer is often not detected until it has reached an advanced stage, time is an important factor in its treatment. At the Lung Cancer Center at Cancer Treatment Centers of America® (CTCA) in Tulsa, the many aspects of your care—from diagnostics and consultations to treatments and follow-up visits—are coordinated and delivered under one roof, so you don’t have to worry about driving from location to location, and so you can start your personalized treatment plan as quickly as possible.

Our team of lung cancer specialists, led by Interventional Pulmonologist Dr. Daniel Nader, works together to deliver a treatment plan tailored to your needs. Each patient’s plan is individualized and based on new and emerging technologies, including genomic-based cancer care, immunotherapy, stereotactic body radiotherapy, brachytherapy and photodynamic therapy, and supplemented with evidence-informed supportive therapies to manage side effects.

The comprehensive care model at CTCA® is designed to educate you on the options available to treat your specific lung cancer type and stage, so you can make informed decisions about your care.

Our Lung Cancer Center doctors

Our oncologists, surgeons, interventional pulmonologists and other Lung Cancer Center doctors collaborate regularly to help meet your needs and treatment goals. Their combined knowledge, training and expertise is gleaned from years spent treating not just cancer, but lung cancer specifically.

The Lung Cancer Center team is led by fellowship-trained, board-certified Pulmonologist Dr. Daniel Nader, who has been recognized by Castle Connolly, U.S. News & World Report and Oklahoma magazine as a top doctor in pulmonary medicine, as well as a top cancer doctor in America in 2015. In addition to his role as director of the Tulsa Lung Cancer Center team, Dr. Nader serves as Chief of the Division of Pulmonary Services for the Department of Medicine at CTCA.

In his position as Thoracic Surgeon on the Lung Cancer Center team, Dr. Peter Baik is trained and experienced in minimally invasive thoracic procedures, including laparoscopic, video-assisted thoracic and robotic surgery. He is double-board certified in general and cardiothoracic surgery by the American Osteopathic Board of Surgery. 

Board-Certified Radiation Oncologist Dr. Douglas Kelly has authored and served as principal investigator for several research protocols, and has presented on numerous radiation therapy topics at national conferences. Dr. Kendal Hervert, a Pulmonologist on the Lung Cancer Center team, completed a fellowship in pulmonary medicine at Oklahoma State University Medical Center in Tulsa and is a member of several professional organizations, including the American College of Chest Physicians, the American Thoracic Society and the American Osteopathic Association. Dr. Theodore Pollock, the Director of Medical Oncology at our Tulsa hospital, is board certified by the American Osteopathic Board of Internal Medicine and is a fellow of the American College of Osteopathic Internists. He also completed a fellowship in medical oncology at Memorial Sloan-Kettering Cancer Center in New York.

Read more about the doctors on the Lung Cancer Center team below.

Nationally recognized expertise

Joint Commission Logo

The Lung Cancer Center at CTCA in Tulsa has been recognized with the Gold Seal of Approval® for Lung Cancer Certification by The Joint Commission, the nation‘s oldest and largest health care accreditation organization. The Gold Seal of Approval is a symbol of quality that reflects an organization‘s commitment to providing safe and effective patient care. The Joint Commission‘s Disease-Specific Care Certification evaluates clinical programs across the continuum of care and addresses three core areas: compliance with consensus-based national standards; effective use of evidence-based clinical practice guidelines to manage and optimize care; and an organized approach to performance measurement and improvement activities.

A comprehensive team approach

Our doctors are critical to the Lung Cancer Center, but they do not work alone. Rather, they are part of a wider, collaborative team of experts who work in concert—conferring regularly with you and with one another—to design and implement a comprehensive, personalized care plan tailored to your individual needs and treatment goals. Each patient is assigned a dedicated care team of doctors, nurses and supportive care clinicians—led by a medical oncologist and coordinated by a care manager—who are focused on two simultaneous missions: to treat your cancer while helping you manage related side effects so they have less of an impact on your well-being and quality of life.

That’s why, in addition to a pulmonologist, oncologists and other physicians, your Lung Cancer Center care team may also include various supportive care clinicians to help you maintain your strength and stamina while combating side effects like pain, fatigue, nausea and breathing challenges, either from cancer or its treatments. Evidence-informed therapies such as nutrition counseling, naturopathic medicine, chiropractic care and massage may be recommended to help you feel and function better—before, during and after treatment. Respiratory therapists trained in smoking cessation techniques also are available if you need help quitting tobacco.

For patients with compromised airways due to their cancer and who are experiencing blockages in their nose, mouth, throat, larynx, trachea or bronchial tubes, we offer additional services tailored to your needs, including advanced diagnostic radiology techniques, speech pathology therapies and pulmonary rehabilitation services.

Also, because lung cancer has a high rate of recurrence, the Lung Cancer Center team will follow up with you after treatment is complete, scheduling regular, routine scans, clinical evaluations and chest X-rays to monitor your progress, even after you’ve returned home.

Quality of life

Conventional treatments plus supportive therapies

The Lung Cancer Center in Tulsa is committed to the CTCA integrative care model, treating cancer with conventional treatments like chemotherapy and radiation, while supporting patients’ quality of life and well-being with supportive therapies that help them manage cancer-related side effects.

Lung cancer patients often experience side effects like fatigue, appetite loss, pain, nausea or neuropathy. To help you prepare for and address these impacts, your care plan may include supportive therapies, such as acupuncture, spiritual support, physical therapy and nutrition.

Learn more about how integrative cancer treatment may help you manage your lung cancer journey.

Lung cancer clinical trials

As part of our commitment to provide our patients with innovative, advanced treatment options, we offer a number of clinical trials at the Lung Cancer Center in Tulsa, especially in the use of interventional pulmonology and chemotherapy. Clinical trials offer patients access to drugs and other treatments that may not otherwise be available to them. See our Clinical Trials Q&A to learn more. Find out about the various lung cancer trials underway at CTCA.

Clinical trials Q & A

Are they only available to patients who have exhausted other lung cancer treatment options?
Lung cancer patients may qualify to participate in a clinical trial at any stage of their treatment journey. Some patients may join a clinical trial when they first start treatment, in conjunction with standard therapy, on the chance it may offer improved outcomes. Other trials are designed for lung cancer patients who have not responded adequately to conventional treatments. Your Lung Cancer Center oncologist will discuss the options and risks, and explain the various protocols involved.
How does CTCA select the trials it offers?
At CTCA, our Lung Cancer Center experts never stop searching for innovative ways to treat lung cancer. Offering carefully selected clinical trials helps us fulfill that mission. The new generation of precision drugs is generally designed to deliver more targeted, less toxic therapies. Our Lung Cancer Center oncologists decide to participate as a clinical trial site only after careful consideration of the relative benefit to patients.
Who may benefit from lung cancer clinical trials?
The answer is based on a case-by-case analysis of each lung cancer patient. This is a time of rapid scientific advances in lung cancer treatment. New surgical techniques are being developed with a goal of attacking lung tumors while reducing the amount of trauma to healthy tissue. Meanwhile, a new generation of lung cancer therapies is designed to attack tumors that have specific genomic mutations. These new targeted treatments may be more effective and cause fewer side effects than traditional chemotherapy. But they are so specialized that only a limited subset of lung cancer patients qualifies for participation. The immunotherapy drug nivolumab, for example, is approved for patients with non-squamous non-small cell lung cancer who have already tried platinum-based chemotherapy or EGFR- or ALK-targeted agents. Genomic tumor testing may determine whether you are a candidate. Other factors—such as your cancer mutations and stage, how you have responded to past treatments and other individual considerations—may also determine whether you qualify for specific trials.
How do I find out whether a specific clinical trial may benefit me?
Your Lung Center oncologist and care team may recommend a trial depending on your individual needs and treatment goals. Learn more about ongoing clinical trials at CTCA. For general questions, e-mail the clinical trials team at clinicaltrials@ctca-hope.com or contact an Oncology Information Specialist at 888-841-9129.
Cancer Types
Our Doctors